Role of oxidative stress in diabetes-mediated vascular dysfunction: Unifying hypothesis of diabetes revisited

被引:139
作者
Schaffer, Stephen W. [1 ]
Jong, Chian Ju [1 ]
Mozaffari, Mahmood [2 ]
机构
[1] Univ S Alabama, Dept Pharmacol, Mobile, AL 36688 USA
[2] Med Coll Georgia, Dept Oral Biol, Augusta, GA 30912 USA
关键词
Glyceraldehyde-3-phosphate dehydrogenase inactivation by ribosylation; Diabetic complications; Oxidative stress; Vascular damage; NITRIC-OXIDE SYNTHASE; PROTEIN-KINASE-C; ALDOSE REDUCTASE EXPRESSION; GLYCATION END-PRODUCTS; ENDOTHELIUM-DEPENDENT RELAXATION; CORONARY-HEART-DISEASE; SMOOTH-MUSCLE-CELLS; NAD(P)H OXIDASE; NADPH OXIDASE; MITOCHONDRIAL-SUPEROXIDE;
D O I
10.1016/j.vph.2012.03.005
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Oxidative stress is recognized as a key participant in the development of diabetic complications in the vasculature. One of the seminal studies advancing the role of oxidative stress in vascular endothelial cells proposed that oxidative stress-mediated diversion of glycolytic intermediates into pathological pathways was a key underlying element in the development of diabetic complications. It is widely recognized that flux through glycolysis slows during diabetes. However, several bottlenecks develop in the glycolytic pathway, including glucose transport, phosphofructokinase, glyceraldehyde-3-phosphate dehydrogenase and pyruvate kinase. Of these limiting steps in glycolysis, glyceraldehyde-3-phosphate dehydrogenase is most sensitive to oxidative stress, leading to the hypothesis that glyceraldehyde-3-phosphate inactivation by ribosylation underlies the diversion of glycolytic intermediates into pathological pathways. However, recent studies question the mechanism underlying the effect of reactive oxygen species on key enzymes of the glycolytic pathway. The present review critiques the major premises of the hypothesis and concludes that further study of the role of oxidative stress in the development of diabetes-mediated vasculature dysfunction is warranted. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:139 / 149
页数:11
相关论文
共 155 条
[1]
How hyperglycemia promotes atherosclerosis: molecular mechanisms [J].
Aronson, Doron ;
Rayfield, Elliot J. .
CARDIOVASCULAR DIABETOLOGY, 2002, 1 (1)
[2]
High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men -: 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study [J].
Balkau, B ;
Shipley, M ;
Jarrett, RJ ;
Pyörälä, K ;
Pyörälä, M ;
Forhan, A ;
Eschwège, E .
DIABETES CARE, 1998, 21 (03) :360-367
[3]
Glyceraldehyde-3-phosphate dehydrogenase activity as an independent modifier of methylglyoxal levels in diabetes [J].
Beisswenger, PJ ;
Howell, SK ;
Smith, K ;
Szwergold, BS .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2003, 1637 (01) :98-106
[4]
Stoichiometric relationships between endothelial tetrahydrobiopterin, endothelial NO synthase (eNOS) activity, and eNOS coupling in vivo - Insights from transgenic mice with endothelial-targeted GTP cyclohydrolase 1 and eNOS overexpression [J].
Bendall, JK ;
Alp, NJ ;
Warrick, N ;
Cai, SJ ;
Adlam, D ;
Rockett, K ;
Yokoyama, M ;
Kawashima, S ;
Channon, KM .
CIRCULATION RESEARCH, 2005, 97 (09) :864-871
[5]
Diabetes increases formation of advanced glycation end products on sarco(endo)plasmic reticulum Ca2+-ATPase [J].
Bidasee, KR ;
Zhang, YN ;
Shao, CH ;
Wang, M ;
Patel, KP ;
Dincer, ÜD ;
Besch, HR .
DIABETES, 2004, 53 (02) :463-473
[6]
Inactivation of glyceraldehyde-3-phosphate dehydrogenase by fumarate in diabetes - Formation of S-(2-succinyl)cysteine, a novel chemical modification of protein and possible biomarker of mitochondrial stress [J].
Blatnik, Matthew ;
Frizzell, Norma ;
Thorpe, Suzanne R. ;
Baynes, John W. .
DIABETES, 2008, 57 (01) :41-49
[7]
Biochemistry and molecular cell biology of diabetic complications [J].
Brownlee, M .
NATURE, 2001, 414 (6865) :813-820
[8]
ADVANCED GLYCOSYLATION PRODUCTS QUENCH NITRIC-OXIDE AND MEDIATE DEFECTIVE ENDOTHELIUM-DEPENDENT VASODILATATION IN EXPERIMENTAL DIABETES [J].
BUCALA, R ;
TRACEY, KJ ;
CERAMI, A .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (02) :432-438
[9]
Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension [J].
Butler, R ;
Morris, AD ;
Belch, JJF ;
Hill, A ;
Struthers, AD .
HYPERTENSION, 2000, 35 (03) :746-751
[10]
Oxidative stress and diabetic cardiomyopathy: A brief review [J].
Cai L. ;
Kang Y.J. .
Cardiovascular Toxicology, 2001, 1 (3) :181-193